Clinical Trials Logo

Filter by:
NCT ID: NCT05361837 Recruiting - Analgesia Clinical Trials

Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery

Start date: May 10, 2022
Phase: N/A
Study type: Interventional

This study aims to compare single level serratus block versus bilevel serratus block with and without dexmedetomidine in cancer patients undergoing modified radical mastectomy for breast cancer regarding pain control and possible side effects.

NCT ID: NCT05361642 Recruiting - Drug Use Clinical Trials

Regional Nasal Block and Dexmedetomidine in Endoscopic Sinus Surgery

Start date: February 3, 2022
Phase: N/A
Study type: Interventional

The purpose is to compare the efficacy of combined regional nasal block and general anesthesia versus general anesthesia with dexmedetomidine during endoscopic sinus surgery in optimizing intraoperative surgical field.

NCT ID: NCT05361525 Recruiting - Abdomen Enlarged Clinical Trials

Lipoabdominoplasty With Anatomic Definition Versus Traditional Abdominoplasty

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

A tummy tuck also known as abdominoplasty is a cosmetic surgical procedure to improve the shape and appearance of the abdomen.

NCT ID: NCT05360940 Recruiting - Clinical trials for Dyspepsia Abdominal Burning Pain Diarrhea Dysentery

Concomitant Infection of Intestinal Parasites and Helicobacter Pylori

Start date: September 2022
Phase:
Study type: Observational

Intestinal parasitic infections such as Giardia lamblia, Entamoeba histolyica and Enterobius Vermicularis are among the most common infections worldwide.So parasitic infections are considered one of the major health problems in the world especially in developing countries. Helicobacter pylori is a gram-negative,helical-shaped,motile bacillus bacterium,which colonizes the gastric mucosa. H.pylori bacterium secretes urease,a special enzyme that converts urea to ammonia. Ammonia reduces the stomach's acidity .This risk factor allows pathogenic intestinal protozoa such as G.lamblia to take the opportunity to cross through the stomach's increased pH and cause disease.

NCT ID: NCT05359510 Recruiting - Incisional Hernia Clinical Trials

The Use of Different Types of Mesh for Prevention of Incisional Hernia Versus Primary Abdominal Suturing

Start date: April 26, 2022
Phase: N/A
Study type: Interventional

The use of different types of mesh at different sites in prevention of incisional hernia after various abdominal incision versus primary abdominal suturing.

NCT ID: NCT05358678 Recruiting - Cesarean Section Clinical Trials

Cesarean Section Scar Niche: The Impact on ART Outcome

Start date: May 25, 2022
Phase:
Study type: Observational

To evaluate the impact of the presence of cesarean section niche and its characteristics on the outcome of ART cycles.

NCT ID: NCT05358275 Recruiting - Odontogenic Cysts Clinical Trials

The Evaluation of the Effect of Performing Guided Lid Surgery

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

to evaluate the percentage of bone volume regain along with postoperative pain in cases done using the bone lid technique in comparison with those done using the conventional cyst enucleation technique.

NCT ID: NCT05352906 Recruiting - Glaucoma Clinical Trials

Accuracy of Handheld and Non-contact Tonometry

Start date: April 20, 2022
Phase: N/A
Study type: Interventional

Monitoring the intraocular pressure (IOP) is one of the most important tests used in follow-up among glaucoma suspects and confirmed glaucomatous patients.

NCT ID: NCT05351619 Recruiting - Clinical trials for Ventilator Associated Pneumonia

Implementing Oral Care Bundle on Critical Care Nurses' Practice and Mechanically Ventilated Patients' Outcomes

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

Oral care is a fundamental aspect of nursing that impact the health and comfort of patients over both the short and long term. Caring for very sick patients in a busy stressful environment may result in oral care having a lower priority for nurses than other aspects of care (Sarangi, Simon, & Sarangi, 2021). Negligence of these interventions can cause long-term oral problems and nosocomial diseases most notably VAP (Abd Alraheem, 2020). A study conducted by Ayşe et al. (2019) reported that the application of regular oral care for the MV patients as a part of care protocols decreased bacterial colonization and had a protective and improving effect on oral health. A recent study conducted by Rizk, Saad-eldeen and Helmy (2020) concluded that VAP is a serious ICU acquired infection with significant impact and required effective preventive action. A systematic review conducted by Kharel, Bist and Mishra (2021) concluded that VAP is a critical issue in ICU with a high-cost burden and various interventional educational programs like staff training and hygiene awareness can reduce the future risk of VAP. A recent study conducted by Abd Alraheem (2020) illustrated that 53.3% of the MV patients had average oral alteration. Asystematic review conducted by Kharel et al. (2021) to assess VAP among ICU patients in WHO South east Asian region illustrated that the VAP incidence rate ranged from 0.2% to 11.6% differing greatly between countries. The highest VAP prevalence rate was reported from the medical ICU, India, where as the lowest was from the palliative care ICU, South Korea. In Egypt, analysis of VAP was done in some Egyptian University Hospitals by Fathy, Abdelhafeez, EL-Gilany and Abd Elhafez, (2013) who reported that the incidence of VAP ranged from 16% to 75%, the lowest ratio was in Alexandria University 16% and the highest one in Ain Shams University 75%. The incidence in Mansoura University Hospitals (MUH) was 22.6%. Another recent study conducted by Elkolaly, Bahr, El-Shafey, Basuoni, and Elber (2019) reported that the incidence of VAP in Tanta University Hospitals is still high (38.4%). Many studies investigated the effect of oral care with chlorhexidine on the incidence of VAP and oral health in MV patients (Abd Alraheem, 2020; Collins et al., 2020; Heck, 2012; Moustafa, Tantawey, El-Soussi and Ramadan, 2016; Plantinga et al., 2016). However, the recent reappraisal of the evidence suggests that chlorhexidine does not reduce VAP, causes excess mortality in non-cardiac surgery patients (Dale et al., 2019) and unexpected high incidence of oral mucosal lesions (Plantinga et al., 2016). Moreover, from my empirical experience, chlorhexidine is not available in all Egyptian hospitals because of its economic burden. A study conducted by Moustafa et al. (2016) recommended regular updates about evidence-based guidelines for oral care and its effect on VAP prevention and oral health. The debate of the literature about oral care inspired us to investigate this area.

NCT ID: NCT05351489 Recruiting - Clinical trials for Transurethral Resection of Prostate

Effect of Two Different Doses of Intrathecal Dexmedetomidine as Adjuvant in Elderly Patients Undergoing HoLEP

Start date: May 30, 2022
Phase: Early Phase 1
Study type: Interventional

Transurethral resection of the prostate (TURP) is the most common Surgical intervention for elderly patients with benign prostatic hyperplasia. Spinal anesthesia is the technique of choice in TURP.Intrathecal (IT)adjuvants prolong the duration of spinal anesthesia and postoperative analgesia there by reducing the requirement of postoperative supplement analgesics .The incorporation of adjuvants also lowers the overall dose of local anesthetic and associated side effects . The extended analgesic efficacy of intratheacal dexmedetomidine in the postoperative period has been shown in a few clinical studies . These authors have studied different doses (2 - 10 μg) of intrathecal dexametomedine and compared it with various other adjuvants like clonidine, fentanyl, midazolam, buprenorphine, etc., with varying results . The existing studies comparing different doses of intratheacal dexmedetomidine are few. Moreover none of these studies have stressed the dose-response relationship between different doses of intratheacal dexmedetomidine and differential analgesia (DA) defined as the time difference from the offset of motor blockade to the first analgesic requirement on numerical rating scale more than4.